RxDoctor Payments Data

Erin Saltzman

Endocrinology, Diabetes & Metabolism · Pennington, NJNPI 1720033228

Payments from drug & device makers

$7,658in general payments, 2019–2025

Across 76 payments — averaging $100.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$7K
  • Novo Nordisk$322
  • Sanofi-aventis U.S. LLC$196
  • AstraZeneca$131
  • Medtronic$78
  • Merck$74
  • plus $358 from 13 others

What the payments were for

  • Consulting fees$6,50085%
  • Food & beverage$1,15815%

General payments by program year

19
20
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,658 in reported general payments places this provider in the 75th percentile of 367 endocrinology, diabetes & metabolism providers in New Jersey.

See all endocrinology, diabetes & metabolism providers in New Jersey

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metformin Hcl ErMetformin Hcl26$122

Paid to pharmacies, not to this prescriber.

Other endocrinology, diabetes & metabolism in Pennington

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →